A Study to Investigate the Effect of ASP1517 After Intermittent Oral Dosing in Dialysis Chronic Kidney Disease Patients With Anemia Compared With Darbepoetin as a Reference Drug
A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 130 participants.
Also called NCT01888445
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 130 participants
- Sponsor
- Registry
-
NCT01888445
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Japan
- Registry status
- Completed
Technical summary
Registry record NCT01888445. Randomized; quadruple masking; primary purpose treatment. Start 2013-03-28 (actual); primary completion 2014-09-15 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- A Study to Investigate the Effect of ASP1517 After Intermittent Oral Dosing in Dialysis Chronic Kidney Disease Patients With Anemia Compared With Darbepoetin as a Reference Drug
- Condition
- Renal Anemia Associated With Chronic Renal Failure (CRF)
- Intervention (Drug)
- roxadustat
- Intervention (Drug)
- darbepoetin alfa
- Lead sponsor
- Astellas Pharma Inc
Record details
- Record id
cardio:ct-nct01888445- Content hash
696a6e2e5518e522470294ef37437f6d9cbdb804bb9a58a87b9eb934a0ca447d